Sandoz Ancozan 100 mg

Ancozan is a pharmaceutical drug containing Losartan Potassium, used to treat hypertension. Historically, Sandoz was a core part of the Swiss pharmaceutical giant Novartis. However, in October 2023, Sandoz was officially spun off as an independent, publicly traded company.

While the packaging shown still mentions 'a Novartis company', this reflects older stock or transitional labeling. Sandoz is now its own global entity headquartered in Basel, Switzerland, specializing in generic and biosimilar medicines. Manufacturing for such products typically occurs across a global network of facilities in Europe, India, and North America to ensure supply chain stability.